Medications That Can Cause Hyperreflexia as a Side Effect
Several medications, particularly serotonergic agents, can cause hyperreflexia as a side effect, with the most common being selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), and other medications that increase serotonin levels in the central nervous system. 1
Serotonergic Medications Associated with Hyperreflexia
Hyperreflexia is most commonly associated with serotonin syndrome, a potentially life-threatening condition characterized by excessive serotonergic activity in the central nervous system. The following medications can cause hyperreflexia through this mechanism:
Antidepressants
- SSRIs (fluoxetine, paroxetine, sertraline, citalopram, fluvoxamine) 2, 1
- SNRIs (venlafaxine, duloxetine) 1
- Tricyclic antidepressants (amitriptyline, nortriptyline, desipramine) 2, 1
- MAOIs (phenelzine, isocarboxazid, moclobemide, isoniazid) 2, 1
- Other antidepressants (bupropion, mirtazapine, trazodone) 2, 3
Other Medications
- Opioids (tramadol, meperidine, methadone, fentanyl) 2, 1
- Stimulants (amphetamines, methylphenidate) 2, 3
- Over-the-counter medications containing dextromethorphan or chlorpheniramine 2, 1
- Antimigraine drugs (triptans) 1
- Antiemetics (ondansetron, metoclopramide) 1
- Antibiotics (linezolid - acts as an MAOI) 2, 1
- Herbal supplements (St. John's wort, L-tryptophan) 2
Medication Combinations with Highest Risk
The risk of hyperreflexia significantly increases when combining multiple serotonergic medications, particularly:
- MAOI + any serotonergic drug (highest risk combination) 2, 1
- Multiple SSRIs or an SSRI with another serotonergic agent 1
- Antidepressants + opioids with serotonergic effects 2, 1
- Antidepressants + illicit drugs (ecstasy, methamphetamine, cocaine, LSD) 2, 4
Clinical Presentation of Hyperreflexia in Serotonin Syndrome
When hyperreflexia occurs as part of serotonin syndrome, it is typically accompanied by:
- Mental status changes (confusion, agitation, anxiety)
- Neuromuscular abnormalities (tremor, clonus, rigidity)
- Autonomic hyperactivity (hypertension, tachycardia, hyperthermia)
- In severe cases: fever >38°C, seizures, and potentially death 1, 5
Risk Factors for Developing Hyperreflexia
Certain factors increase the risk of developing hyperreflexia from medications:
- Advanced age (older adults have higher risk) 6
- Higher medication doses (dose-dependent relationship) 6
- Combination therapy with multiple serotonergic agents 6
- Drug interactions affecting metabolism of serotonergic medications 1
- Recent dose increases or medication changes 2
Management of Medication-Induced Hyperreflexia
If hyperreflexia is detected:
- Discontinue all serotonergic agents immediately 1
- Provide supportive care including IV fluids 1
- Administer benzodiazepines for agitation control 1
- Consider cyproheptadine (12 mg initially, max 32 mg daily) for moderate to severe cases 1
- Monitor for complications such as rhabdomyolysis, metabolic acidosis, and renal failure 1
Prevention Strategies
To prevent medication-induced hyperreflexia:
- Avoid combining MAOIs with any other serotonergic medications 2, 1
- Exercise caution when combining two or more non-MAOI serotonergic drugs 2, 1
- Start second serotonergic medications at low doses and increase slowly 2
- Monitor closely for symptoms in the first 24-48 hours after medication changes 2
- Educate patients about early signs of serotonin syndrome 1
Important Caveats
- Hyperreflexia can occur with monotherapy but is much more common with combination therapy 4
- Symptoms typically develop within 24-48 hours after starting or increasing the dose of a serotonergic medication 1
- Without proper treatment, mortality rate can reach approximately 11% 1
- Physical restraints should be avoided as they may worsen hyperthermia 1